298 related articles for article (PubMed ID: 32740006)
1. Descemet Stripping Only Supplemented With Topical Ripasudil for Fuchs Endothelial Dystrophy 12-Month Outcomes of the Sydney Eye Hospital Study.
Moloney G; Garcerant Congote D; Hirnschall N; Arsiwalla T; Luiza Mylla Boso A; Toalster N; D'Souza M; Devasahayam RN
Cornea; 2021 Mar; 40(3):320-326. PubMed ID: 32740006
[TBL] [Abstract][Full Text] [Related]
2. Descemetorhexis Without Grafting for Fuchs Endothelial Dystrophy-Supplementation With Topical Ripasudil.
Moloney G; Petsoglou C; Ball M; Kerdraon Y; Höllhumer R; Spiteri N; Beheregaray S; Hampson J; DʼSouza M; Devasahayam RN
Cornea; 2017 Jun; 36(6):642-648. PubMed ID: 28476048
[TBL] [Abstract][Full Text] [Related]
3. Use of Topical Rho Kinase Inhibitors in the Treatment of Fuchs Dystrophy After Descemet Stripping Only.
Macsai MS; Shiloach M
Cornea; 2019 May; 38(5):529-534. PubMed ID: 30720541
[TBL] [Abstract][Full Text] [Related]
4. Potential Functional Restoration of Corneal Endothelial Cells in Fuchs Endothelial Corneal Dystrophy by ROCK Inhibitor (Ripasudil).
Schlötzer-Schrehardt U; Zenkel M; Strunz M; Gießl A; Schondorf H; da Silva H; Schmidt GA; Greiner MA; Okumura N; Koizumi N; Kinoshita S; Tourtas T; Kruse FE
Am J Ophthalmol; 2021 Apr; 224():185-199. PubMed ID: 33316261
[TBL] [Abstract][Full Text] [Related]
5. Descemet Endothelial Thickness Comparison Trial 1 (DETECT 1): outcome masked, placebo-controlled trial comparing two types of corneal transplant surgeries and effect of rho kinase inhibitors on endothelial cell loss protocol.
Chamberlain W; Lin CC; Li JY; Gensheimer W; Clover J; Jeng BH; Varnado N; Abdelrahman S; Arnold BF; Lietman TM; Rose-Nussbaumer J
BMJ Open Ophthalmol; 2024 Jan; 9(1):. PubMed ID: 38286566
[TBL] [Abstract][Full Text] [Related]
6. Descemet stripping only in Fuchs' endothelial dystrophy without use of topical Rho-kinase inhibitors: 5-year follow-up.
Iovieno A; Moramarco A; Fontana L
Can J Ophthalmol; 2022 Dec; 57(6):402-407. PubMed ID: 34283965
[TBL] [Abstract][Full Text] [Related]
7. Descemet Stripping Only: Long-Term Outcomes.
Hakim FE; Nagra AK; Dhaliwal DK
Cornea; 2024 Aug; 43(8):994-998. PubMed ID: 37921677
[TBL] [Abstract][Full Text] [Related]
8. Descemet Membrane Endothelial Keratoplasty versus Ultrathin Descemet Stripping Automated Endothelial Keratoplasty: A Multicenter Randomized Controlled Clinical Trial.
Dunker SL; Dickman MM; Wisse RPL; Nobacht S; Wijdh RHJ; Bartels MC; Tang ML; van den Biggelaar FJHM; Kruit PJ; Nuijts RMMA
Ophthalmology; 2020 Sep; 127(9):1152-1159. PubMed ID: 32386811
[TBL] [Abstract][Full Text] [Related]
9. Five-Year Follow-up of First 11 Patients Undergoing Injection of Cultured Corneal Endothelial Cells for Corneal Endothelial Failure.
Numa K; Imai K; Ueno M; Kitazawa K; Tanaka H; Bush JD; Teramukai S; Okumura N; Koizumi N; Hamuro J; Sotozono C; Kinoshita S
Ophthalmology; 2021 Apr; 128(4):504-514. PubMed ID: 32898516
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Fuchs Endothelial Dystrophy by Descemet Stripping Without Endothelial Keratoplasty.
Borkar DS; Veldman P; Colby KA
Cornea; 2016 Oct; 35(10):1267-73. PubMed ID: 27310885
[TBL] [Abstract][Full Text] [Related]
11. Descemet Stripping Endothelial Keratoplasty for Fuchs' Endothelial Corneal Dystrophy: Five-Year Results of a Prospective Study.
Wacker K; Baratz KH; Maguire LJ; McLaren JW; Patel SV
Ophthalmology; 2016 Jan; 123(1):154-60. PubMed ID: 26481820
[TBL] [Abstract][Full Text] [Related]
12. Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Transiently Alters the Morphology of Corneal Endothelial Cells.
Okumura N; Okazaki Y; Inoue R; Nakano S; Fullwood NJ; Kinoshita S; Koizumi N
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7560-7. PubMed ID: 26618648
[TBL] [Abstract][Full Text] [Related]
13. Pilot Study of Corneal Clearance With the Use of a Rho-Kinase Inhibitor After Descemetorhexis Without Endothelial Keratoplasty for Fuchs Endothelial Corneal Dystrophy.
Davies E; Jurkunas U; Pineda R
Cornea; 2021 Jul; 40(7):899-902. PubMed ID: 33758139
[TBL] [Abstract][Full Text] [Related]
14. Descemet's stripping without endothelial keratoplasty.
Garcerant D; Hirnschall N; Toalster N; Zhu M; Wen L; Moloney G
Curr Opin Ophthalmol; 2019 Jul; 30(4):275-285. PubMed ID: 31033737
[TBL] [Abstract][Full Text] [Related]
15. Cataract surgery in patients with Fuchs' endothelial corneal dystrophy: when to consider a triple procedure.
van Cleynenbreugel H; Remeijer L; Hillenaar T
Ophthalmology; 2014 Feb; 121(2):445-53. PubMed ID: 24289914
[TBL] [Abstract][Full Text] [Related]
16. One-Year Clinical Outcomes of Preloaded Descemet Membrane Endothelial Keratoplasty Versus Non-Preloaded Descemet Membrane Endothelial Keratoplasty.
Böhm MS; Wylegala A; Leon P; Ong Tone S; Ciolino JB; Jurkunas UV
Cornea; 2021 Mar; 40(3):311-319. PubMed ID: 32740011
[TBL] [Abstract][Full Text] [Related]
17. Fuchs' endothelial corneal dystrophy: a controlled prospective study on visual recovery after endothelial keratoplasty.
Nielsen E; Ivarsen A; Kristensen S; Hjortdal J
Acta Ophthalmol; 2016 Dec; 94(8):780-787. PubMed ID: 27273977
[TBL] [Abstract][Full Text] [Related]
18. The First 100 Eyes of Standardized Descemet Stripping Automated Endothelial Keratoplasty versus Standardized Descemet Membrane Endothelial Keratoplasty.
Hamzaoglu EC; Straiko MD; Mayko ZM; Sáles CS; Terry MA
Ophthalmology; 2015 Nov; 122(11):2193-9. PubMed ID: 26271841
[TBL] [Abstract][Full Text] [Related]
19. Descemet stripping only and ripasudil for the treatment of traumatic Descemet's membrane ruptures.
Fernández López E; Montolío-Marzo S; Ortega Pérez C; Catalán Gómez M; Peris Martínez C; Piá Ludeña JV; Chan E
Eur J Ophthalmol; 2023 Jul; 33(4):NP13-NP18. PubMed ID: 35435049
[TBL] [Abstract][Full Text] [Related]
20. Randomized, Double-Masked, Pilot Study of Netarsudil 0.02% Ophthalmic Solution for Treatment of Corneal Edema in Fuchs Dystrophy.
Price MO; Price FW
Am J Ophthalmol; 2021 Jul; 227():100-105. PubMed ID: 33737034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
